Home of the CloneCard, OspreyBio provides researchers with the first comprehensive toolset able to create multi-target therapeutic candidates. Powered by the Bird of Prey (BoP) system, CloneCard genes are easily assembled together, creating a multitude of new possibilities for bringing gene and cell therapy into the future. Visit our website, https://ospreybio.com to learn more!
| Website | https://ospreybio.com |
| Employees | 5 (3 on RocketReach) |
| Industry | Manufacturing |
| Keywords | Therapeutic Candidates, Biotechnology, Drug Discovery, Research Tools, Genetic Engineering, Biopharmaceutical, Molecular Biology, Life Sciences, Protein Engineering, Synthetic Biology, Gene Synthesis, Genome Editing, Crispr, Biotech, Pharmaceutical Research, Drug Development, Bioscience |
| Competitors | Novartis, AstraZeneca, Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Biogen, Receptos, a wholly-owned subsidiary of Celgene, Lilly India, Sarepta Therapeutics, Inc. +35 more (view full list) |
Looking for a particular Osprey BioScience employee's phone or email?
Thomas Reed is the Founder and President of Osprey BioScience.
3 people are employed at Osprey BioScience.
Osprey BioScience is based in Frederick, Maryland.